{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:41:35Z","timestamp":1759365695816,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.peptides.2020.170390","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:19:04Z","timestamp":1598872744000},"page":"170390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure"],"prefix":"10.1016","volume":"134","author":[{"given":"Camilla L.","family":"Asferg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Linneberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula L.","family":"Hedley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4320-8015","authenticated-orcid":false,"given":"J\u00f8rgen L.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2020.170390_bib0005","doi-asserted-by":"crossref","first-page":"H12","DOI":"10.1152\/ajpheart.00226.2011","article-title":"Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones","volume":"301","author":"Clerico","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(92)90011-Y","article-title":"Brain natriuretic peptide as a cardiac hormone in essential hypertension","volume":"92","author":"Kohno","year":"1992","journal-title":"Am J Med."},{"key":"10.1016\/j.peptides.2020.170390_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10741-011-9249-z","article-title":"The paradox of low BNP levels in obesity","volume":"17","author":"Clerico","year":"2012","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.peptides.2020.170390_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.111.00791","article-title":"Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men","volume":"62","author":"Asferg","year":"2013","journal-title":"Hypertension."},{"key":"10.1016\/j.peptides.2020.170390_bib0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajh\/hpy029","article-title":"Obese hypertensive men have lower circulating proatrial natriuretic peptide concentrations despite greater left atrial size","volume":"31","author":"Asferg","year":"2018","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.peptides.2020.170390_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/heartjnl-2016-309462","article-title":"Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men","volume":"103","author":"Asferg","year":"2017","journal-title":"Heart"},{"issue":"Suppl D","key":"10.1016\/j.peptides.2020.170390_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/14.suppl_D.8","article-title":"Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease","volume":"14","author":"Devereux","year":"1993","journal-title":"Eur Heart J."},{"key":"10.1016\/j.peptides.2020.170390_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.jhh.1001167","article-title":"The ECG and left ventricular hypertrophy in primary care hypertensives","volume":"15","author":"Conway","year":"2001","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.peptides.2020.170390_bib0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4250\/jcu.2011.19.4.169","article-title":"Use and limitations of E\/e\u2019 to assess left ventricular filling pressure by echocardiography","volume":"19","author":"Park","year":"2011","journal-title":"J Cardiovasc Ultrasound."},{"key":"10.1016\/j.peptides.2020.170390_bib0050","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","article-title":"A test in context: E\/A and E\/e\u2032 to assess diastolic dysfunction and LV filling pressure","volume":"69","author":"Mitter","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0055","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","article-title":"European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring","volume":"32","author":"Parati","year":"2014","journal-title":"J Hypertens."},{"key":"10.1016\/j.peptides.2020.170390_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.peptides.2020.170390_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.echo.2015.05.002","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)","volume":"28","author":"Marwick","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.peptides.2020.170390_bib0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0140-6736(90)90925-U","article-title":"Human brain natriuretic peptide, a novel cardiac hormone","volume":"335","author":"Mukoyama","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2020.170390_bib0080","first-page":"245","article-title":"Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension","volume":"7","author":"Buckley","year":"1993","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.peptides.2020.170390_bib0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9343(00)00364-8","article-title":"Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension","volume":"108","author":"Suzuki","year":"2000","journal-title":"Am J Med."},{"key":"10.1016\/j.peptides.2020.170390_bib0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1291\/hypres.25.669","article-title":"Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events","volume":"25","author":"Suzuki","year":"2002","journal-title":"Hypertens Res."},{"key":"10.1016\/j.peptides.2020.170390_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejheart.2004.12.010","article-title":"BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy","volume":"7","author":"Lukowicz","year":"2005","journal-title":"Eur J Heart Fail."},{"issue":"6","key":"10.1016\/j.peptides.2020.170390_bib0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000399","article-title":"Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening","volume":"2","author":"Xanthakis","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.peptides.2020.170390_bib0105","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.jacc.2018.02.071","article-title":"B-type natriuretic peptide levels and mortality in patients with and without heart failure","volume":"71","author":"York","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12574-011-0086-9","article-title":"Determinants of plasma brain natriuretic peptide levels in untreated hypertensive patients","volume":"9","author":"Goda","year":"2011","journal-title":"J Echocardiogr."},{"key":"10.1016\/j.peptides.2020.170390_bib0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ahj.2004.02.016","article-title":"Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings","volume":"148","author":"Mak","year":"2004","journal-title":"Am Heart J."},{"key":"10.1016\/j.peptides.2020.170390_bib0120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ahj.2006.07.010","article-title":"B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures","volume":"152","author":"Taylor","year":"2006","journal-title":"Am Heart J."},{"key":"10.1016\/j.peptides.2020.170390_bib0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.118.11081","article-title":"Natriuretic peptides in cardiovascular and metabolic crosstalk: implications for hypertension management","volume":"72","author":"Jordan","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.peptides.2020.170390_bib0130","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.orcp.2011.04.001","article-title":"Decreased plasma B-type natriuretic peptide levels in obesity are not explained by altered left ventricular hemodynamics","volume":"5","author":"Fukuta","year":"2011","journal-title":"Obes Res Clin Pract."},{"issue":"1","key":"10.1016\/j.peptides.2020.170390_bib0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001265","article-title":"Weight loss, saline loading, and the natriuretic peptide system","volume":"4","author":"Arora","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.peptides.2020.170390_bib0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ajh\/hpt145","article-title":"Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men","volume":"27","author":"Asferg","year":"2014","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.peptides.2020.170390_bib0145","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1210\/jc.2011-2839","article-title":"Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?","volume":"97","author":"Pivovarova","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.peptides.2020.170390_bib0150","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1152\/ajpregu.00499.2015","article-title":"Insulin\/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway","volume":"311","author":"Bordicchia","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ijo.2010.227","article-title":"Neprilysin, obesity and the metabolic syndrome","volume":"35","author":"Standeven","year":"2011","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.peptides.2020.170390_bib0160","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","author":"Lam","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.peptides.2020.170390_bib0165","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2018.12.062","article-title":"Effect of testosterone on natriuretic peptide levels","volume":"73","author":"Bachmann","year":"2019","journal-title":"J Am Coll Cardiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812030139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812030139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:27:21Z","timestamp":1759310841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697812030139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S019697812030139X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170390","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170390"}}